Barclays
NBEV

Barclays’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History

Barclays’s Portfolio NBEV Stock Details NBEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,700
Closed -$4K – 5739
2020
Q2 		$4K Sell
2,700
-39,700
-94% -$59.3K ﹤0.01% 5414
2020
Q1 		$59K Buy
42,400
+7,900
+23% +$14.2K ﹤0.01% 5125
2019
Q4 		$63K Buy
34,500
+12,800
+59% +$30.3K ﹤0.01% 5674
2019
Q3 		$60K Sell
21,700
-8,500
-28% -$30K ﹤0.01% 5814
2019
Q2 		$141K Buy
30,200
+25,300
+516% +$130K ﹤0.01% 5415
2019
Q1 		$26K Buy
+4,900
New +$29.5K ﹤0.01% 6251

Other funds holding NBEV

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

Barclays's NBEV Position: Q3 2022 in Review

Barclays sold out of NewAge, Inc. Common Stock (Delaware) (NBEV) in Q3 2022, closing a stake of 971 shares.

Barclays first reported a position in NBEV in Q3 2017 and held it in 13 quarters. The position peaked at $2.94M in Q4 2018. 12 funds tracked by Wall St. Rank hold NBEV as of Q3 2022.

  • Barclays reported no remaining NewAge, Inc. Common Stock (Delaware) position as of Q3 2022 after selling out during the quarter.
  • Barclays sold 971 NewAge, Inc. Common Stock (Delaware) shares in Q3 2022.
  • Barclays first reported a position in NewAge, Inc. Common Stock (Delaware) in Q3 2017 and held it in 13 quarters.
  • Barclays's NewAge, Inc. Common Stock (Delaware) position peaked at $2.94M in Q4 2018.
  • 12 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.